Baricitinib

Brand Name

Olumiant192

Pharmacology

Janus kinase 1 and 2 inhibitor

FDA Indication

Rheumatoid arthritis

Similars

Ruxolitinib, tofacitinib

Further Reading in Goodman & Gilman’s